has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 1.5422 crores during the period ended December 31, 2021 as compared to Rs. 2.8372 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -0.0476 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.2588 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -0.12 for the period ended December 31, 2021 as compared to Rs. 0.65 for the period ended September 30, 2021.
Total Income | ₹ 1.5422 crs | ₹2.8372 crs | -45.64% |
Net Profit | ₹-0.0476 crs | ₹0.2588 crs | -118.39% |
EPS | ₹-0.12 | ₹0.65 | -118.46% |
Financial Results (Q3 FY2022) - YoY Comparison The company has reported total income of Rs. 1.5422 crores during the period ended December 31, 2021 as compared to Rs.4.1206 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-0.0476 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.1657 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-0.12 for the period ended December 31, 2021 as compared to Rs.0.41 for the period ended December 31, 2020.
Total Income | ₹ 1.5422 crs | ₹4.1206 crs | -62.57% |
Net Profit | ₹-0.0476 crs | ₹0.1657 crs | -128.73% |
EPS | ₹-0.12 | ₹0.41 | -129.27% |
Financial Results (9 Months Ended FY2022) - YoY Comparison The company has reported total income of Rs.5.0890 crores during the 9 Months period ended December 31, 2021 as compared to Rs.3.8144 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.5330 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.09 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.1.33 for the 9 Months period ended December 31, 2021 as compared to Rs.0.23 for the 9 Months period ended December 31, 2020.
Total Income | ₹5.0890 crs | ₹3.8144 crs | 33.42% |
Net Profit | ₹0.5330 crs | ₹0.09 crs | 492.22% |
EPS | ₹1.33 | ₹0.23 | 478.26% |
Source : Equity Bulls
Keywords
VivanzaBiosciences
Q3FY22
9MFY22
ResultUpdate
VSSL